Accelerating lymphoma research
The LYSARC, in collaboration with the LYSA independent clinical research network, conducts major clinical studies in the field of lymphoma research. The AHL 2011 phase 3 study and the real-life study REALYSA are two examples of this. The results of the AHL 2011 study defined a new care standard for advanced Hodgkin lymphomas: the PET-guided treatment strategy. As for the REALYSA, this is an unprecedented real-life study with 6,000 French patients suffering from various types of lymphomas, monitored over a period of 9 years. Objectives: improving the available knowledge and opening the possibility of new lymphoma research projects.